• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌病中的二尖瓣修复

Mitral valve repair in cardiomyopathy.

作者信息

Chen F Y, Adams D H, Aranki S F, Collins J J, Couper G S, Rizzo R J, Cohn L H

机构信息

Division of Cardiac Surgery, Brigham and Women's Hospital, Boston, MA 02115, USA.

出版信息

Circulation. 1998 Nov 10;98(19 Suppl):II124-7.

PMID:9852893
Abstract

BACKGROUND

Volume overload secondary to mitral regurgitation (MR) in cardiomyopathy is considered critical in the pathogenesis of subsequent ventricular dysfunction. Open mitral valve repair (OMVP) is hypothesized to improve symptomatology and ventricular function by reducing the volume overload of the left ventricle.

METHODS AND RESULTS

All patients who underwent OMVP with a left ventricular ejection fraction (EF) of < 0.30 (n = 81) from 1984 through 1997 were reviewed (1 patient was lost to follow-up). Fifteen operations (18.5%) were repeat operations after previous coronary artery bypass graft surgery. Preoperative and postoperative EFs and NYHA class were compared. Survival probabilities were calculated, and multivariate analysis was performed. The average age of all patients was 67.1 years (range, 41 to 83 years). Mean follow-up was 1.7 years (range, 2 months to 8.5 years). The most common mitral repair was ring annuloplasty. Sixty-two patients (77%) had concomitant coronary artery bypass graft surgery. The surgery mortality rate was 11% (9 of 81); 6 of these 9 patients were > 70 years old. The overall Kaplan-Meier survival probability rate at 1, 2, 3, 4, and 5 years was 0.73, 0.68, 0.58, 0.50, and 0.38, respectively. EF improved significantly (0.24 to 0.32; P < 0.0001), as did the NYHA class (3.2 to 1.6; P < 0.0001), at follow-up. There was no difference in late survival between patients with an EF of < 0.20 (21 patients) and those with an EF between 0.20 and 0.30 (P = NS). Risk factors for death included heart failure and old age.

CONCLUSIONS

OMVP for MR in the setting of ischemic cardiomyopathy and low EF appear to improve ventricular function, medium-term patient symptomatology, and survival.

摘要

背景

心肌病中二尖瓣反流(MR)继发的容量超负荷被认为在随后心室功能障碍的发病机制中至关重要。开放式二尖瓣修复术(OMVP)被认为可通过减轻左心室的容量超负荷来改善症状和心室功能。

方法与结果

回顾了1984年至1997年间所有接受OMVP且左心室射血分数(EF)<0.30的患者(n = 81)(1例患者失访)。15例手术(18.5%)是在先前冠状动脉搭桥手术后的再次手术。比较术前和术后的EF及纽约心脏协会(NYHA)分级。计算生存概率,并进行多因素分析。所有患者的平均年龄为67.1岁(范围41至83岁)。平均随访时间为1.7年(范围2个月至8.5年)。最常见的二尖瓣修复术是环缩成形术。62例患者(77%)同时进行了冠状动脉搭桥手术。手术死亡率为11%(81例中的9例);这9例患者中有6例年龄>70岁。1、2、3、4和5年时的总体Kaplan-Meier生存概率分别为0.73、0.68、0.58、0.50和0.38。随访时EF显著改善(从0.24至0.32;P<0.0001),NYHA分级也显著改善(从3.2至1.6;P<0.0001)。EF<0.20的患者(21例)与EF在0.20至0.30之间的患者的晚期生存率无差异(P=无显著性差异)。死亡的危险因素包括心力衰竭和高龄。

结论

在缺血性心肌病和低EF情况下进行的OMVP似乎可改善心室功能、中期患者症状及生存率。

相似文献

1
Mitral valve repair in cardiomyopathy.心肌病中的二尖瓣修复
Circulation. 1998 Nov 10;98(19 Suppl):II124-7.
2
Mitral regurgitation surgery in patients with ischemic cardiomyopathy and ischemic mitral regurgitation: factors that influence survival.缺血性心肌病并缺血性二尖瓣反流患者的二尖瓣反流手术:影响生存的因素。
J Thorac Cardiovasc Surg. 2011 Nov;142(5):995-1001. doi: 10.1016/j.jtcvs.2011.07.044. Epub 2011 Aug 19.
3
Restrictive mitral valve annuloplasty for chronic ischemic mitral regurgitation: a 5-year clinical experience with the physio ring.用于慢性缺血性二尖瓣反流的限制性二尖瓣环成形术:使用生理环的5年临床经验
Heart Surg Forum. 2008;11(4):E225-30. doi: 10.1532/HSF98.20081028.
4
Early and late results of restrictive mitral valve annuloplasty in 121 patients with cardiomyopathy and chronic mitral regurgitation.121例心肌病合并慢性二尖瓣反流患者限制性二尖瓣环成形术的早期和晚期结果
Thorac Cardiovasc Surg. 2008 Aug;56(5):262-8. doi: 10.1055/s-2008-1038420.
5
Does mitral valve intervention have an impact on late survival in ischemic cardiomyopathy?二尖瓣干预对缺血性心肌病的晚期生存率有影响吗?
Isr Med Assoc J. 2006 Jan;8(1):17-20.
6
Mitral valve repair versus revascularization alone in the treatment of ischemic mitral regurgitation.二尖瓣修复术与单纯血运重建术治疗缺血性二尖瓣反流的比较。
Circulation. 2006 Jul 4;114(1 Suppl):I499-503. doi: 10.1161/CIRCULATIONAHA.105.000398.
7
Early and long-term outcome of mitral valve repair with a Cosgrove band combined with coronary revascularization in patients with ischemic cardiomyopathy and moderate-severe mitral regurgitation.在缺血性心肌病合并中重度二尖瓣反流患者中,采用科斯格罗夫带进行二尖瓣修复联合冠状动脉血运重建的早期和长期结果。
J Heart Valve Dis. 2008 Jul;17(4):396-401.
8
Mitral valve surgery in patients with poor left ventricular function.左心室功能不佳患者的二尖瓣手术
Thorac Cardiovasc Surg. 2002 Dec;50(6):351-4. doi: 10.1055/s-2002-35746.
9
Patient survival characteristics after routine mitral valve repair for ischemic mitral regurgitation.缺血性二尖瓣反流常规二尖瓣修复术后的患者生存特征。
J Thorac Cardiovasc Surg. 2005 Apr;129(4):860-8. doi: 10.1016/j.jtcvs.2004.11.023.
10
Mitral reconstruction in cardiomyopathy.心肌病中的二尖瓣重建
J Heart Valve Dis. 2002 Jan;11 Suppl 1:S26-31.

引用本文的文献

1
Study protocol for an international registry observational study evaluating clinical outcomes of transcatheter versus standard surgical mitral valve operation for secondary mitral regurgitation: the TEERMISO study.一项国际注册观察性研究的研究方案,该研究旨在评估经导管二尖瓣手术与标准外科二尖瓣手术治疗继发性二尖瓣反流的临床结局:TEERMISO研究
BMJ Open. 2025 Jan 8;15(1):e086888. doi: 10.1136/bmjopen-2024-086888.
2
A Protocol Investigation Comparing Transcatheter Repair with the Standard Surgical Procedure for Secondary Mitral Regurgitation.一项比较经导管修复与二尖瓣反流标准外科手术的方案研究。
J Clin Med. 2024 Dec 18;13(24):7742. doi: 10.3390/jcm13247742.
3
Outcomes of transcatheter edge-to-edge mitral valve repair with percutaneous coronary intervention vs. surgical mitral valve repair with coronary artery bypass grafting.
经导管二尖瓣缘对缘修复术联合经皮冠状动脉介入治疗与二尖瓣手术修复联合冠状动脉旁路移植术的疗效比较。
Front Cardiovasc Med. 2022 Dec 21;9:953875. doi: 10.3389/fcvm.2022.953875. eCollection 2022.
4
Organ-saving surgical alternatives to treatment of heart failure.治疗心力衰竭的保留器官手术替代方案。
Cardiovasc Diagn Ther. 2021 Feb;11(1):213-225. doi: 10.21037/cdt-20-285.
5
Ischemic Mitral Regurgitation: Current Understanding and Surgical Options.缺血性二尖瓣反流:当前的认识与手术选择
Indian J Thorac Cardiovasc Surg. 2020 Jan;36(Suppl 1):27-33. doi: 10.1007/s12055-019-00811-4. Epub 2019 Apr 6.
6
Valvular regurgitation and stenosis: when is surgery required?瓣膜反流与狭窄:何时需要手术?
Heart Asia. 2009 Jan 1;1(1):20-5. doi: 10.1136/ha.2008.000315. eCollection 2009.
7
Adjuvant Pericardial Sac Restraining in Heart Failure Treatment. A Medical Hypothesis Illustrated by a Case Report.辅助心包囊限制术在心力衰竭治疗中的应用。一项通过病例报告阐述的医学假说
Braz J Cardiovasc Surg. 2016 Feb;31(1):66-9. doi: 10.5935/1678-9741.20160004.
8
Posterior annulus shortening increases leaflet coaptation in ischemic mitral incompetence: a new and valid technique.后瓣环缩短增加缺血性二尖瓣关闭不全的瓣叶对合:一种新的有效技术。
Ann Cardiothorac Surg. 2015 May;4(3):238-48. doi: 10.3978/j.issn.2225-319X.2015.04.07.
9
Surgical treatment of functional mitral regurgitation in dilated cardiomyopathy.扩张型心肌病功能性二尖瓣反流的外科治疗
J Saudi Heart Assoc. 2011 Jul;23(3):125-34. doi: 10.1016/j.jsha.2011.04.001. Epub 2011 Apr 16.
10
[Coronary sinus devices for treatment of functional mitral valve regurgitation. Solution or dead end?].[用于治疗功能性二尖瓣反流的冠状静脉窦装置。是解决方案还是死胡同?]
Herz. 2013 Aug;38(5):490-500. doi: 10.1007/s00059-013-3866-3.